https://biotechmorning.com/news/fda-generative-ai-medical-devices-public-input Biotech Morning en 2026-08-19T14:17:52.222Z The FDA Just Asked the Internet How to Regulate AI Doctors https://biotechmorning.com/news/sandoz-henlius-biosimilar-licensing-deal Biotech Morning en 2026-08-19T14:17:07.560Z Sandoz Just Went Shopping in Shanghai. Here's What It Bought. https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-pregnancy Biotech Morning en 2026-08-19T14:16:22.484Z America's Only Syphilis Drug for Pregnant Women Just Got Recalled https://biotechmorning.com/news/eikon-therapeutics-ipo-381-million-wall-street-shrugged Biotech Morning en 2026-08-19T14:15:43.259Z Eikon Therapeutics Just Raised $381M. Wall Street Shrugged. https://biotechmorning.com/news/enveda-exercise-pill-lac-phe-obesity-maintenance Biotech Morning en 2026-08-19T14:14:56.560Z The Pill That Wants to Trick Your Body Into Thinking It Just Worked Out https://biotechmorning.com/news/tagrisso-combo-bet-lung-cancer-resistance Biotech Morning en 2026-08-19T14:14:08.269Z Tagrisso's Second Act: The Combo Bet That Could Rewrite Lung Cancer Resistance https://biotechmorning.com/news/genbio-ai-aido-cell-virtual-cell Biotech Morning en 2026-08-19T14:13:17.174Z A Nobel Laureate Thinks He Can Simulate an Entire Human Cell https://biotechmorning.com/news/csl-best-day-25-years-plasma-earnings Biotech Morning en 2026-08-19T14:12:24.738Z CSL Just Had Its Best Day in 25 Years. Here's What Lit the Fuse. https://biotechmorning.com/news/argenx-forte-biosciences-acquisition-2-2-billion Biotech Morning en 2026-08-19T14:11:37.810Z Argenx Just Dropped $2.2 Billion on a Company Most People Haven't Heard Of https://biotechmorning.com/news/lilly-orna-therapeutics-circular-rna-acquisition Biotech Morning en 2026-08-19T14:10:48.062Z Lilly Just Paid $2.4 Billion for a Circle. Here's Why. https://biotechmorning.com/news/personalized-mrna-cancer-vaccine-phase-3-melanoma Biotech Morning en 2026-08-19T14:10:05.110Z The Cancer Vaccine That's Built From Scratch for Every Single Patient https://biotechmorning.com/news/fda-approves-cancer-killing-virus-melanoma Biotech Morning en 2026-08-18T14:17:37.589Z The FDA Just Approved a Cancer-Killing Virus. Yes, Really. https://biotechmorning.com/news/pathos-ai-alphamab-jskn016-2-billion-deal Biotech Morning en 2026-08-18T14:16:53.383Z The $2 Billion Bet on a Cancer Drug You've Never Heard Of https://biotechmorning.com/news/regeneron-eye-trial-halted-safety-review Biotech Morning en 2026-08-18T14:15:56.760Z Regeneron's Eye Just Blinked https://biotechmorning.com/news/leo-pharma-dersimelagon-deal-435-million Biotech Morning en 2026-08-18T14:15:16.400Z LEO Pharma Just Paid $435M for a Drug That Isn't Approved Yet https://biotechmorning.com/news/amylyx-avexitide-post-bariatric-hypoglycemia-comeback Biotech Morning en 2026-08-18T14:14:32.092Z Amylyx's Unlikely Comeback Started With a Sugar Crash https://biotechmorning.com/news/argenx-vyvgart-myositis-phase-3-win Biotech Morning en 2026-08-18T14:13:42.031Z Argenx Just Cracked Open a New Market (With One Asterisk) https://biotechmorning.com/news/fulcrum-slate-medicines-reverse-merger-nasdaq Biotech Morning en 2026-08-18T14:12:56.717Z Fulcrum Gutted Its Pipeline. Then It Became Someone Else's Ride to Nasdaq. https://biotechmorning.com/news/evaxion-kills-tumor-vaccine-bets-on-brain-cancer Biotech Morning en 2026-08-18T14:12:14.076Z Evaxion Just Killed Its Tumor Vaccine. What It's Betting On Instead Is Wild. https://biotechmorning.com/news/sanofi-blueprint-medicines-layoffs-post-acquisition Biotech Morning en 2026-08-18T14:11:25.480Z Sanofi Bought Blueprint Medicines for $9.5 Billion. Then Cut a Third of Its People.